Diabete tipo 2, semaglutide per via orale riduce attacchi cuore e ictus: lo studio

Diabete tipo 2, semaglutide per via orale riduce attacchi cuore e ictus: lo studio

(Adnkronos) – Presentato a Chicago al meeting dell’American College of Cardiology

Read More

Tag: Nessun tag

Add a Comment

Your email address will not be published. Required fields are marked *